| Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial D Sebag-Montefiore, RJ Stephens, R Steele, J Monson, R Grieve, ... The Lancet 373 (9666), 811-820, 2009 | 1855 | 2009 |
| Effect of the plane of surgery achieved on local recurrence in patients with operable rectal cancer: a prospective study using data from the MRC CR07 and NCIC-CTG CO16 … P Quirke, R Steele, J Monson, R Grieve, S Khanna, J Couture, ... The Lancet 373 (9666), 821-828, 2009 | 1278* | 2009 |
| Long-term outcomes of clinical complete responders after neoadjuvant treatment for rectal cancer in the International Watch & Wait Database (IWWD): an international multicentre … MJM Van der Valk, DE Hilling, E Bastiaannet, EMK Kranenbarg, GL Beets, ... The Lancet 391 (10139), 2537-2545, 2018 | 978 | 2018 |
| Watch-and-wait approach versus surgical resection after chemoradiotherapy for patients with rectal cancer (the OnCoRe project): a propensity-score matched cohort analysis AG Renehan, L Malcomson, R Emsley, S Gollins, A Maw, AS Myint, ... The Lancet Oncology 17 (2), 174-183, 2016 | 806 | 2016 |
| Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label … RD James, R Glynne-Jones, HM Meadows, D Cunningham, AS Myint, ... The lancet oncology 14 (6), 516-524, 2013 | 752 | 2013 |
| Past, present, and future of radiotherapy for the benefit of patients J Thariat, JM Hannoun-Levi, A Sun Myint, T Vuong, JP Gérard Nature reviews Clinical oncology 10 (1), 52-60, 2013 | 517 | 2013 |
| Conditional recurrence-free survival of clinical complete responders managed by watch and wait after neoadjuvant chemoradiotherapy for rectal cancer in the International Watch … LM Fernandez, GP São Julião, NL Figueiredo, GL Beets, ... The Lancet Oncology 22 (1), 43-50, 2021 | 166 | 2021 |
| Factors affecting local regrowth after watch and wait for patients with a clinical complete response following chemoradiotherapy in rectal cancer (InterCoRe consortium): an … SA Chadi, L Malcomson, J Ensor, RD Riley, CA Vaccaro, GL Rossi, ... The lancet Gastroenterology & hepatology 3 (12), 825-836, 2018 | 157 | 2018 |
| Radical surgery versus organ preservation via short-course radiotherapy followed by transanal endoscopic microsurgery for early-stage rectal cancer (TREC): a randomised, open … SP Bach, A Gilbert, K Brock, S Korsgen, I Geh, J Hill, T Gill, P Hainsworth, ... The lancet Gastroenterology & hepatology 6 (2), 92-105, 2021 | 150 | 2021 |
| International consensus recommendations on key outcome measures for organ preservation after (chemo) radiotherapy in patients with rectal cancer E Fokas, A Appelt, R Glynne-Jones, G Beets, R Perez, J Garcia-Aguilar, ... Nature Reviews Clinical Oncology 18 (12), 805-816, 2021 | 147 | 2021 |
| Personalized management of elderly patients with rectal cancer: expert recommendations of the European Society of Surgical Oncology, European Society of Coloproctology … I Montroni, G Ugolini, NM Saur, A Spinelli, S Rostoft, M Millan, A Wolthuis, ... European Journal of Surgical Oncology 44 (11), 1685-1702, 2018 | 132 | 2018 |
| Dose escalation using contact X-ray brachytherapy after external beam radiotherapy as nonsurgical treatment option for rectal cancer: outcomes from a single-center experience AS Myint, FML Smith, S Gollins, H Wong, C Rao, K Whitmarsh, ... International Journal of Radiation Oncology* Biology* Physics 100 (3), 565-573, 2018 | 95 | 2018 |
| Neoadjuvant chemoradiotherapy with radiation dose escalation with contact x-ray brachytherapy boost or external beam radiotherapy boost for organ preservation in early cT2–cT3 … JP Gerard, N Barbet, R Schiappa, N Magné, I Martel, L Mineur, ... The Lancet Gastroenterology & Hepatology 8 (4), 356-367, 2023 | 81 | 2023 |
| Multi‐modality approach in curative local treatment of early rectal carcinomas MJ Hershman, AS Myint, CA Makin Colorectal Disease 5 (5), 445-450, 2003 | 80 | 2003 |
| Preoperative chemoradiotherapy using concurrent capecitabine and irinotecan in magnetic resonance imaging–defined locally advanced rectal cancer: Impact on long-term clinical … S Gollins, A Sun Myint, B Haylock, M Wise, M Saunders, R Neupane, ... Journal of clinical oncology 29 (8), 1042-1049, 2011 | 79 | 2011 |
| Ireland (ACPGBI): guidelines for the management of cancer of the colon, rectum and anus (2017)-multidisciplinary management S Gollins, B Moran, R Adams, C Cunningham, S Bach, AS Myint, ... Colorectal Dis 19 (Suppl 1), 37-66, 2017 | 72 | 2017 |
| Combined modality treatment of early rectal cancer—the UK experience AS Myint, RJ Grieve, AC McDonald, EL Levine, S Ramani, K Perkins, ... Clinical oncology 19 (9), 674-681, 2007 | 64 | 2007 |
| Renaissance of contact x-ray therapy for treating rectal cancer JP Gérard, AS Myint, O Croce, J Lindegaard, A Jensen, R Myerson, ... Expert review of medical devices 8 (4), 483-492, 2011 | 58 | 2011 |
| Older cancer patients during the COVID-19 epidemic: practice proposal of the International Geriatric Radiotherapy Group NP Nguyen, V Vinh-Hung, BG Baumert, A Zamagni, M Arenas, M Motta, ... Cancers 12 (5), 1287, 2020 | 54 | 2020 |
| Association of Coloproctology of Great Britain & Ireland (ACPGBI): Guidelines for the management of cancer of the colon, rectum and anus (2017)-multidisciplinary management. S Gollins, B Moran, R Adams, C Cunningham, S Bach, AS Myint, ... Colorectal Disease 19, 2017 | 54 | 2017 |
Rob Glynne-JonesMount Vernon Centre for Cancer TreatmentVerified email at nhs.net
